To describe a unique case of a patient with bipolar I disorder who developed acute mania following lurasidone titration, emphasizing the clinical significance of monitoring.
Key Findings:
The patient exhibited increased energy and decreased sleep needs after one week of lurasidone treatment.
By the second week, he developed a full manic episode characterized by elevated mood, irritability, intrusive behavior, and significant sleep reduction.
Immediate discontinuation of lurasidone and optimization of sodium valproate led to a dramatic reduction in manic symptoms.
Interpretation:
This case highlights the need for vigilance in monitoring for manic symptoms during lurasidone treatment in patients with bipolar I disorder, which is crucial for effective management.
Limitations:
The case is based on a single patient, limiting generalizability.
The patient's inconsistent adherence to mood stabilizers may have influenced the outcome, introducing potential bias.
Conclusion:
Close monitoring for manic symptoms is critical following lurasidone initiation in patients with bipolar I disorder to prevent adverse outcomes.
